Accès gratuit
Numéro
Med Sci (Paris)
Volume 27, Numéro 2, Février 2011
Page(s) 183 - 186
Section M/S revues
DOI https://doi.org/10.1051/medsci/2011272183
Publié en ligne 8 mars 2011
  1. Civitareale D, Lonigro R, Sinclair AJ, Di Lauro R. A thyroid-specific nuclear protein essential for tissue-specific expression of the thyroglobulin promoter. EMBO J 1989 ; 8 : 2537-2542. [PubMed]
  2. Lazzaro D, Price M, de Felice M, Di Lauro R. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 1991 ; 113 : 1093-1104. [PubMed]
  3. Kimura S, Hara Y, Pineau T, et al.. The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 1996 ; 10 : 60-69. [CrossRef] [PubMed]
  4. Katoh R, Kawaoi A, Miyagi E, et al.. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization. Mod Pathol 2000 ; 13 : 570-576. [CrossRef] [PubMed]
  5. Bejarano PA, Nikiforov YE, Swenson ES, Biddinger PW. Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms. Appl Immunohistochem Mol Morphol 2000 ; 8 : 189-194. [CrossRef] [PubMed]
  6. Ziad el A, Ruchala M, Breborowicz J, et al.. Immunoexpression of TTF-1 and Ki-67 in a coexistent anaplastic and follicular thyroid cancer with rare long-life surviving. Folia Histochem Cytobiol 2008 ; 46 : 461-464. [CrossRef] [PubMed]
  7. Ohmori M, Ohta M, Shimura H, et al. Cloning of the single strand DNA-binding protein important for maximal expression and thyrotropin (TSH)-induced negative regulation of the TSH receptor. Mol Endocrinol 1996 ; 10 : 1407-1424. [CrossRef] [PubMed]
  8. Fabbro D, Di Loreto C, Beltrami CA, et al.. Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms. Cancer Res 1994 ; 54 : 4744-4749. [PubMed]
  9. Fenton CL, Patel A, Burch HB, Tuttle RM, Francis GL. Nuclear localization of thyroid transcription factor-1 correlates with serum thyrotropin activity and may be increased in differentiated thyroid carcinomas with aggressive clinical course. Ann Clin Lab Sci 2001 ; 31 : 245-252. [PubMed]
  10. Lv H, Zhang S, Wang B, Cui S, Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release 2006 ; 114 : 100-109. [CrossRef] [PubMed]
  11. Gudmundsson J, Sulem P, Gudbjartsson DF, et al. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 2009 ; 41 : 460-464. [CrossRef] [PubMed]
  12. Chen G, Jiang Q, You Z, et al. Regulation of GSK-3 beta in the proliferation and apoptosis of human thyrocytes investigated using a GSK-3 beta-targeting RNAi adenovirus expression vector: involvement the Wnt/beta-catenin pathway. Mol Biol Reports 2010 ; 37 : 2773-2779. [CrossRef]
  13. Bohinski RJ, Bejarano PA, Balko G, Warnick RE, Whitsett JA. Determination of lung as the primary site of cerebral metastatic adenocarcinomas using monoclonal antibody to thyroid transcription factor-1. J NeuroOncol 1998 ; 40 : 227-231. [CrossRef] [PubMed]
  14. Kwei KA, Kim YH, Girard L, et al. Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. oncogene 2008 ; 27 : 3635-3640. [CrossRef] [PubMed]
  15. Garraway LA, Sellers WR. Lineage dependency and lineage-survival oncogenes in human cancer. Nat Rev Cancer 2006 ; 6 : 593-602. [CrossRef] [PubMed]
  16. Asa SL. My approach to oncocytic tumours of the thyroid. J Clin Pathol 2004 ; 57 : 225-232. [CrossRef] [PubMed]
  17. Oliveira AM, Tazelaar HD, Myers JL, et al. Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites. Am J Surg Pathol 2001 ; 25 : 815-819. [CrossRef] [PubMed]
  18. Ordonez NG. Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas. Adv Anat Pathol 2000 ; 7 : 123-127. [CrossRef] [PubMed]
  19. Jagirdar J. Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung. Arch Pathol Lab Med 2008 ; 132 : 384-396. [PubMed]
  20. Marchevsky AM. Application of immunohistochemistry to the diagnosis of malignant mesothelioma. Arch Pathol Lab Med 2008 ; 132 : 397-401. [PubMed]
  21. Byrd-Gloster AL, Khoor A, Glass LF, et al. Differential expression of thyroid transcription factor 1 in small cell lung carcinoma and Merkel cell tumor. Hum Pathol 2000 ; 31 : 58-62. [CrossRef] [PubMed]
  22. Puglisi F, Aprile G, Bruckbauer M, et al. Combined analysis of MIB-1 and thyroid transcription factor-1 predicts survival in non-small cell lung carcinomas. Cancer Lett 2001 ; 162 : 97-103. [CrossRef] [PubMed]
  23. Barletta JA, Perner S, Iafrate AJ, et al. Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma. J Cell Mol Med 2009 ; 13 : 1977-1986. [CrossRef] [PubMed]
  24. Anagnostou VK, Syrigos KN, Bepler G, et al. Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma. J Clin Oncol 2009 ; 27 : 271-278. [CrossRef] [PubMed]
  25. Kitamura H, Yazawa T, Sato H, et al. Small cell lung cancer: significance of RB alterations and TTF-1 expression in its carcinogenesis, phenotype, and biology. Endocr Pathol 2009 ; 20 : 101-107. [CrossRef] [PubMed]
  26. Zhang P, Zuo H, Nakamura Y, et al. Immunohistochemical analysis of thyroid-specific transcription factors in thyroid tumors. Pathol Int 2006 ; 56 : 240-245. [CrossRef] [PubMed]
  27. Ngan ES, Lang BH, Liu T, et al.. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma. J Natl Cancer Inst 2009 ; 101 : 162-175. [CrossRef] [PubMed]
  28. Puglisi F, Barbone F, Damante G, et al. Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma. Mod Pathol 1999 ; 12 : 318-324. [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.